Patients with depression and comorbid obesity may be more prone to weight modulating and cardiovascular side effects of selected antidepressants (AD). It is important to ascertain whether these AD prescriptions differ by patient weight status.
Référence bibliographique
Puzhko, S., Schuster, T., Barnett, T. A., Renoux, C., Munro, K., Barber, D. et Bartlett, G. (2021). Difference in patterns of prescribing antidepressants known for their weight-modulating and cardiovascular side effects for patients with obesity compared to patients with normal weight. Journal of Affective Disorders, 295, 1310-1318.
